Domenico D'Amico

Summary

Country: Italy

Publications

  1. ncbi request reprint [The Vigimig study of naratriptan use in general practice]
    Michel Lanteri-Minet
    Service de Neurologie, Hopital Pasteur, Nice
    Presse Med 36:1536-44. 2007
  2. ncbi request reprint Measuring responses to therapy in headache patients: new and traditional end-points
    D D'Amico
    National Neurological Institute C Besta, Via Celoria 11, I 20123 Milan, Italy
    Neurol Sci 25:S108-10. 2004
  3. doi request reprint Disability in chronic daily headache: state of the art and future directions
    Domenico D'Amico
    Headache Center, Neurological Institute C Besta IRCCS Foundation, Via Celoria 11, 20133 Milan, Italy
    Neurol Sci 32:S71-6. 2011
  4. ncbi request reprint Early treatment of migraine attacks with triptans: a strategy to enhance outcomes and patient satisfaction?
    Domenico D'Amico
    C Besta National Neurological Institute, Clinical Neurosciences Department, Via Celoria 11, 20133 Milano, Italy
    Expert Rev Neurother 6:1087-97. 2006
  5. ncbi request reprint Migraine preventive therapy: selection of appropriate patients and general principles of management
    Domenico D'Amico
    C Besta National Neurological Institute, Via Celoria 11, 20133 Milano, Italy
    Expert Rev Neurother 6:1147-57. 2006
  6. ncbi request reprint Antiepileptic drugs in the prophylaxis of migraine, chronic headache forms and cluster headache: a review of their efficacy and tolerability
    D D'Amico
    Fondazione IRCCS Istituto Neurologico C Besta, Via Celoria 11, I 20123 Milan, Italy
    Neurol Sci 28:S188-97. 2007
  7. doi request reprint Does closure of a patent foramen ovale have a role in the treatment of migraine with aura?
    Domenico D'Amico
    Department of Clinical Neurosciences Department, C Besta Neurological Institute, Via Celoria 11, 20133 Milan, Italy
    Neurol Sci 29:S23-7. 2008
  8. doi request reprint When should "chronic migraine" patients be considered "refractory" to pharmacological prophylaxis?
    Domenico D'Amico
    Department of Clinical Neurosciences, C Besta Neurological Institute, Via Celoria 11, 20133 Milan, Italy
    Neurol Sci 29:S55-8. 2008
  9. doi request reprint Polytherapy for the prophylaxis of chronic migraine: an Italian survey
    D D'Amico
    Headache Center, Neurological Institute C Besta IRCCS Foundation, Milan, Italy
    Neurol Sci 32:S185-8. 2011
  10. doi request reprint Pharmacological prophylaxis of chronic migraine: a review of double-blind placebo-controlled trials
    Domenico D'Amico
    U O Neurologia III Cefalee, Fondazione IRCCS Istituto Neurologico C Besta, Via Celoria 11, 20133, Milan, Italy
    Neurol Sci 31:S23-8. 2010

Collaborators

Detail Information

Publications46

  1. ncbi request reprint [The Vigimig study of naratriptan use in general practice]
    Michel Lanteri-Minet
    Service de Neurologie, Hopital Pasteur, Nice
    Presse Med 36:1536-44. 2007
    ..France has developed official guidelines for the use of triptans as part of migraine management. This pharmacoepidemiological study sought to evaluate how naratriptan is prescribed and used in community medicine in France...
  2. ncbi request reprint Measuring responses to therapy in headache patients: new and traditional end-points
    D D'Amico
    National Neurological Institute C Besta, Via Celoria 11, I 20123 Milan, Italy
    Neurol Sci 25:S108-10. 2004
    ..However, further studies to determine the suitability of these instruments as outcome measures in clinical practice are necessary...
  3. doi request reprint Disability in chronic daily headache: state of the art and future directions
    Domenico D'Amico
    Headache Center, Neurological Institute C Besta IRCCS Foundation, Via Celoria 11, 20133 Milan, Italy
    Neurol Sci 32:S71-6. 2011
    ....
  4. ncbi request reprint Early treatment of migraine attacks with triptans: a strategy to enhance outcomes and patient satisfaction?
    Domenico D'Amico
    C Besta National Neurological Institute, Clinical Neurosciences Department, Via Celoria 11, 20133 Milano, Italy
    Expert Rev Neurother 6:1087-97. 2006
    ..This recommendation implies a requirement for patient education and the need to carefully tailor treatment to individual needs...
  5. ncbi request reprint Migraine preventive therapy: selection of appropriate patients and general principles of management
    Domenico D'Amico
    C Besta National Neurological Institute, Via Celoria 11, 20133 Milano, Italy
    Expert Rev Neurother 6:1147-57. 2006
    ....
  6. ncbi request reprint Antiepileptic drugs in the prophylaxis of migraine, chronic headache forms and cluster headache: a review of their efficacy and tolerability
    D D'Amico
    Fondazione IRCCS Istituto Neurologico C Besta, Via Celoria 11, I 20123 Milan, Italy
    Neurol Sci 28:S188-97. 2007
    ..Nevertheless, encouraging data from controlled trials are emerging for TPM in the treatment of chronic headache forms...
  7. doi request reprint Does closure of a patent foramen ovale have a role in the treatment of migraine with aura?
    Domenico D'Amico
    Department of Clinical Neurosciences Department, C Besta Neurological Institute, Via Celoria 11, 20133 Milan, Italy
    Neurol Sci 29:S23-7. 2008
    ..It is recommended that the advantages and risks of PFO closure be carefully assessed in each individual, bearing in mind that effective prophylactic medications are available for MA patients with high attack frequency...
  8. doi request reprint When should "chronic migraine" patients be considered "refractory" to pharmacological prophylaxis?
    Domenico D'Amico
    Department of Clinical Neurosciences, C Besta Neurological Institute, Via Celoria 11, 20133 Milan, Italy
    Neurol Sci 29:S55-8. 2008
    ..However before a definition of "refractory" chronic migraine can become established, generally accepted diagnostic criteria and treatment guidelines for this condition need to be developed...
  9. doi request reprint Polytherapy for the prophylaxis of chronic migraine: an Italian survey
    D D'Amico
    Headache Center, Neurological Institute C Besta IRCCS Foundation, Milan, Italy
    Neurol Sci 32:S185-8. 2011
    ..Our survey indicates that polytherapy may be rather common in CM, and suggests that comorbidities may strongly influence treatment choices...
  10. doi request reprint Pharmacological prophylaxis of chronic migraine: a review of double-blind placebo-controlled trials
    Domenico D'Amico
    U O Neurologia III Cefalee, Fondazione IRCCS Istituto Neurologico C Besta, Via Celoria 11, 20133, Milan, Italy
    Neurol Sci 31:S23-8. 2010
    ....
  11. doi request reprint Key points in migraine prophylaxis: patient perspective
    Domenico D'Amico
    Headache Centre, Department of Neurological Sciences, C Besta Neurological Institute, Via Celoria 11, 20133, Milan, Italy
    Neurol Sci 30:S39-42. 2009
    ..This paper reviews the main factors influencing patient acceptance of anti-migraine prophylaxis, providing practical suggestions to maximize patient agreement with, and adherence to, preventive treatment...
  12. ncbi request reprint Treatment strategies in the acute therapy of migraine: stratified care and early intervention
    D D'Amico
    Headaches and Cerebrovascular Disorders Unit, C Besta National Neurological Institute, Via Celoria 11, I 20133, Milan, Italy
    Neurol Sci 27:S117-22. 2006
    ..Successful implementation of both strategies requires that physicians are well informed, and that they elicit an exhaustive headache history from each patient...
  13. doi request reprint Undertreatment in patients with primary headaches attending headache centres
    Domenico D'Amico
    Headache Centre, Neurological Institute C Besta IRCCS Foundation, Via Celoria 11, 20133 Milan, Italy
    Neurol Sci 32:S181-3. 2011
    ....
  14. ncbi request reprint Topiramate in migraine prophylaxis
    D D'Amico
    U O Cefalee e Malattie Cerebrovascolari, C Besta National Neurological Institute, Via Celoria 11, I 20133, Milan, Italy
    Neurol Sci 26:s130-3. 2005
    ....
  15. ncbi request reprint Workplace disability in migraine: an Italian experience
    D D'Amico
    National Neurological Institute C Besta, Via Celoria 11, I 20133 Milan, Italy
    Neurol Sci 25:S251-2. 2004
    ..Our data confirmed that headaches, and particularly migraine, cause a considerable reduction in workplace productivity. Workplace interventions to effectively manage migraine are needed...
  16. ncbi request reprint Treatment strategies in migraine patients
    D D'Amico
    National Neurological Institute C Besta, Via Celoria 11, I 20133 Milan, Italy
    Neurol Sci 25:S242-3. 2004
    ..Also, the framework of information the patient is given represents an essential component of migraine management, along with his/her active involvement in the therapeutic program and schedule...
  17. ncbi request reprint Prevalence of primary headaches in people with multiple sclerosis
    D D'Amico
    C Besta National Neurological Institute, Milan, Italy
    Cephalalgia 24:980-4. 2004
    ..Further studies are needed to clarify the mechanisms underlying this association, particularly the association between migraine and relapsing-remitting MS, and the role of interferon in the development of new headache...
  18. pmc Chronic migraine classification: current knowledge and future perspectives
    Gian Camillo Manzoni
    Department of Neurosciences, Headache Centre, Istituto di Neurologia, University of Parma, c o Azienda Ospedaliero Universitaria Padiglione Barbieri, 3 piano, Via Gramsci 14, 43100, Parma, Italy
    J Headache Pain 12:585-92. 2011
    ....
  19. doi request reprint Underdiagnosis of primary headaches: results of a survey on patients attending headache centres
    N Massetto
    San Paolo Hospital, Milan, Italy
    Neurol Sci 30:S129-31. 2009
    ....
  20. ncbi request reprint Disability in chronic migraine patients with medication overuse: treatment effects at 1-year follow-up
    Licia Grazzi
    Neurological Institute C Besta, Milan, Italy
    Headache 44:678-83. 2004
    ....
  21. ncbi request reprint Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: outcome at 3 years
    Licia Grazzi
    Headache Center, National Neurological Institute C Besta, Milan, Italy
    Headache 42:483-90. 2002
    ..To determine whether combined treatment using medication and biofeedback would be more effective than drug treatment alone for treating transformed migraine complicated by analgesic overuse...
  22. ncbi request reprint Disability pattern in chronic migraine with medication overuse: a comparison with migraine without aura
    Domenico D'Amico
    National Neurological Institute C Besta, Milan, Italy
    Headache 45:553-60. 2005
    ....
  23. doi request reprint Health-related quality of life, disability and severity of disease in patients with migraine attending to a specialty headache center
    Matilde Leonardi
    Neurology, Public Health and Disability Unit, Scientific Directorate, Neurological Institute C Besta, IRCCS Foundation, Via Celoria 11, Milan, Italy
    Headache 50:1576-86. 2010
    ..The impact of migraine on patients' daily life has been evaluated in several studies. The relationship between disability and health-related quality of life (HRQoL) in patients with migraine, however, has not been systematically evaluated...
  24. doi request reprint Therapeutic neurostimulation in chronic headaches: problems of patient selection
    Massimo Leone
    Headache Centre, National Neurological Institute IRCCS Foundation C Besta, Via Celoria 11, 20133 Milan, Italy
    Neurol Sci 29:S59-61. 2008
    ..We also propose that only completely drug-resistant (as opposed to partially drug-resistant) patients be considered for neurostimulation unless there are other indications...
  25. doi request reprint A longitudinal evaluation of changes in disability and quality of life in a sample of women with migraine
    Alberto Raggi
    Neurology, Public Health and Disability Unit, Neurological Institute C Besta IRCCS Foundation, Via Celoria 11, 20133 Milan, Italy
    Neurol Sci 32:S189-91. 2011
    ..Wider improvements were observed at follow-up for activities in which relational skills are relevant, while those with a physical component, or that are predominantly performed autonomously, remained almost unchanged...
  26. doi request reprint Psychological variables in chronic migraine with medication overuse before and after inpatient withdrawal: results at 1-year follow-up
    Susanna Usai
    Headache Center, National Neurological Institute C Besta, Via Celoria 11, 20133, Milan, Italy
    Neurol Sci 30:S125-7. 2009
    ..The changes of clinical indexes and of psychological parameters are discussed and analyzed in order to address the most adequate therapeutic strategy for this kind of patients...
  27. doi request reprint Microembolic air load during contrast-transcranial Doppler: a trigger for migraine with aura?
    Luigi Caputi
    Department of Cerebrovascular Diseases, Neurological Institute C Besta, Milan, Italy
    Headache 50:1320-7. 2010
    ..The occurrence of MA attacks after microbubble (MB) injection during contrast-enhanced transcranial Doppler (ce-TCD) has been recently described...
  28. doi request reprint Value and utility of disease-specific and generic instruments for assessing disability in patients with migraine, and their relationships with health-related quality of life
    Alberto Raggi
    Neurology, Public Health and Disability Unit, Scientific Directorate, Neurological Institute C Besta, IRCCS Foundation, Via Celoria 11, 20133 Milan, Italy
    Neurol Sci 32:387-92. 2011
    ..Our findings indicate that these issues are relevant for patients' health status and should be taken into account in future research on migraine as important secondary outcomes of treatment interventions...
  29. doi request reprint Disability and functional profiles of patients with migraine measured with ICF classification
    Alberto Raggi
    Neurology, Public Health and Disability Unit Scientific Directorate bHeadache Centre, Neurological Institute C Besta IRCCS Foundation, Milano, Italy
    Int J Rehabil Res 33:225-31. 2010
    ..To plan appropriate interventions that meet patients' needs, especially in the labor sector, methodologies and tools are needed to couple information on symptoms, on the difficulties in executing activities and on environment's features...
  30. doi request reprint Reduction in the impact of chronic migraine with medication overuse after day-hospital withdrawal therapy
    Susanna Usai
    National Neurological Institute C Besta, Headache Center, Via Celoria 11, 20133 Milan, Italy
    Neurol Sci 29:S176-8. 2008
    ..4 (median 65) to 59.4+/-8.5 (median 62) (Student's t-test p<0.00001) and with a reduction in the percentage of patients with very severe headache-related impact one year after withdrawal therapy...
  31. doi request reprint Prevalence and characteristics of right-to-left shunt in migraine with aura: a survey on 120 Italian patients
    L Caputi
    Cerebrovascular Diseases Unit, C Besta Neurological Institute, Milan, Italy
    Neurol Sci 30:S109-11. 2009
    ..We found RLS in 61 of them. A latent RLS was found in 28%, a permanent RLS in 72%, a shower-curtain pattern was detected in 52% of the studied patients...
  32. doi request reprint Application of revised criteria for chronic migraine and medication overuse headache in a tertiary Headache Centre
    Domenico D'Amico
    Department of Neurological Sciences, Fondazione IRCCS Istituto Neurologico C Besta, Milan, Italy
    Neurol Sci 29:S158-60. 2008
    ....
  33. pmc A systematic review of the psychosocial difficulties relevant to patients with migraine
    Alberto Raggi
    Neurology, Public Health and Disability Unit, Neurological Institute C Besta IRCCS Foundation, Milan, Italy
    J Headache Pain 13:595-606. 2012
    ....
  34. doi request reprint A 3-month analysis of disability, quality of life, and disease course in patients with migraine
    Alberto Raggi
    Neurology, Public Health and Disability Unit, Scientific Directorate, Neurological Institute C Besta IRCCS Foundation, Milan, Italy Headaches Center, Neurological Institute C Besta IRCCS Foundation, Milan, Italy
    Headache 53:297-309. 2013
    ....
  35. doi request reprint ICF in neurology: functioning and disability in patients with migraine, myasthenia gravis and Parkinson's disease
    Matilde Leonardi
    Neurology Public Health and Disability Unit Scientific Directorate, Neurological Institute C Besta IRCCS Foundation, Milan, Italy
    Disabil Rehabil 31:S88-99. 2009
    ..To report and compare functional features of patients with migraine, myasthenia gravis (MG) and Parkinson's disease (PD) with the International Classification of Functioning, Disability and Health (ICF)...
  36. pmc Headache, anxiety and depressive disorders: the HADAS study
    Ettore Beghi
    Dipartimento di Neuroscienze, Istituto Mario Negri, Milan, Italy
    J Headache Pain 11:141-50. 2010
    ..This also applied to obsessive-compulsive disorder (OR 4.8; 95% CI 1.1-20.9) in migraine plus tension-type headache. Psychopathology of primary headache can reflect shared risk factors, pathophysiologic mechanisms, and disease burden...
  37. ncbi request reprint Restoring migraine sufferers' ability to function normally: a comparison of rizatriptan and other triptans in randomized trials
    Gennaro Bussone
    National Neurological Institute C Besta, Milan, Italy
    Eur Neurol 48:172-7. 2002
    ..Assessments of treatment efficacy have tended to focus on migraine symptoms, rather than looking at functional impact. This study compared the efficacy of different oral triptans for restoring normal function in migraine sufferers...
  38. doi request reprint Controversies in migraine: monotherapy
    Domenico D'Amico
    Clinical Neurosciences Department, Carlo Besta Neurological Institute IRCCS Foundation, Via Celoria 11, 20133 Milan, Italy
    Neurol Sci 33:S141-5. 2012
    ....
  39. doi request reprint Functioning and disability in migraine
    Matilde Leonardi
    Neurology, Public Health and Disability Unit Scientific Directorate, Neurological Institute C Besta IRCCS Foundation, Via Celoria 11, Milan, 20133 Italy
    Disabil Rehabil 32:S23-32. 2010
    ..To describe functioning and disability in patients with migraine according to the model endorsed by the International Classification of Functioning Disability and Health (ICF)...
  40. doi request reprint Fatal Aspergillus brain abscess in immunocompetent patient
    Marcella Curone
    Neuroscience Department, Neurological Institute Foundation C Besta, 20133, Milan, Italy
    Neurol Sci 30:233-5. 2009
    ..Despite steroids' relative safety, clinicians must remain alert to potential fatal complication that could arise from their use...
  41. ncbi request reprint Migraine, celiac disease, and cerebral calcifications: a new case
    Domenico D'Amico
    Headace Center, National Institute, Milan, Italy
    Headache 45:1263-7. 2005
    ..Visual examination showed bilateral double scotoma, and further investigations revealed celiac disease. Migraine may on occasion be a sentinel symptom of mild celiac disease...
  42. ncbi request reprint Prolonged focal negative motor seizures: a video-EEG study
    Flavio Villani
    Division of Clinical Epileptology, Instituto Nazionale Neurologico C Besta, Milan, Italy
    Epilepsia 47:1949-52. 2006
    ....
  43. doi request reprint Sleep and headache: a bidirectional relationship
    Carlo Lovati
    Headache Centre, Department of Neurology, Luigi Sacco Hospital, Via GB Grassi 74, Milan, Italy
    Expert Rev Neurother 10:105-17. 2010
    ..In the present work the anatomy, physiology and pathology of sleep and head-pain perception will be reviewed with the aim of highlighting the points of contact and possible unifying treatment strategies...
  44. ncbi request reprint Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial
    Hans Christoph Diener
    Department of Neurology, Universitat Duisburg Essen, Germany
    Lancet Neurol 6:1054-62. 2007
    ..We assessed the effects of discontinuation of topiramate after a treatment period of 6 months...
  45. ncbi request reprint Evaluation of efficacy, tolerability, and treatment satisfaction with almotriptan in 3 consecutive migraine attacks. The migraine--satisfaction with treatment: reality with Almogran study
    Helene Massiou
    Service de Neurologie, Hopital Lariboisiere, Paris, France
    Eur Neurol 55:198-203. 2006
    ..Almotriptan 12.5 mg was effective, well-tolerated and associated with a high rate of treatment satisfaction in patients whose previous acute migraine therapy was inadequate according to the ANAES recommendations...
  46. ncbi request reprint Development and validation of the Neuropathic Pain Symptom Inventory
    Didier Bouhassira
    INSERM E 332, Center d Evaluation t de Traitement de la Douleur, Hôspiat Ambroise paré, Boulogne Billancourt, France
    Pain 108:248-57. 2004
    ....